Chihuahua city is the setting for a historic event in the field of research and product development for the Humana health care. Psoriasis is a chronic disease of the skin of multifactorial origin but with a genetic basis; It can affect any region of the skin but with predetermination to the skin of the scalp, elbows, knees and lumbosacral region. Psoriasis affects around two million people drastically reducing their quality of life in Mexico. April 15, 2010 was launched commercially treatment for Psoriasis DERMABON control is a SOAP for daily use that thanks to its formula gradually eliminates all body psoriasis plates returning its original state in a period of 4 to 8 weeks of disciplined use of the treatment. Treatment for psoriasis of DERMABON was tested through a clinical analysis conducted by the school of Medicine of the Tecnologico de Monterrey Campus Chihuahua proving a 93% efficiency in patients with mild, moderate, and intense psoriasis. Dermabon is recommended by: United States FDA (Food and Drug Administration) approved the product for marketing in this country after performing extensive testing of quality of the product and the packaging, certifying that the treatment does not contain cortisone or immunosuppressive agents. The new life without ABP Psoriasis Association. Monterrey Nuevo Leon has tested treatment with great success and DERMABON is currently a product recommended on your website. DERMABON the best treatment for the control of its 2.13% coal activo:alquitran ingredients Psoriasis topically reduces the size and thickness of the skin lesion.Unlike steroids, it is able to make disappear a psoriatic lesion and allow a referral of the same fully or on a temporary basis, but for a period of much greater time and steroidal anti-inflammatory drugs do not produce recurrences, or regrowth after use.